Abstract
Background
An intragastric satiety-inducing device (ISD) (Full Sense Device; Baker, Foote, Kemmeter, Walburn, LLC, Grand Rapids, MI) is a novel weight-loss device, which may induce satiety by applying continuous pressure on the gastric cardia. This study investigated the effect of the ISD on food intake and body weight gain in a rodent model.
Methods
Thirty-two male Sprague–Dawley rats (weight, 250–300 g) were randomly divided into four groups of eight individuals. Single-disk (SD) and double-disk (DD) group animals underwent peroral placement of a single- or double-disk ISD, respectively, under fluoroscopic guidance. The ISD comprised a 4 mm × 1.5 cm nitinol stent placed in the lower esophagus and one (single-disk) or two (double-disk) 2.5-cm-diameter star-shaped nitinol disks placed in the gastric fundus. Esophageal stent (ES) and sham-operated (SO) group animals underwent peroral placement of the ES part of the ISD and a sham operation, respectively.
Results
Food intake was significantly different among the four groups over the 4-week study period (P < 0.001); food intake was significantly lower in the SD and DD groups than in the SO group (P = 0.016 and P = 0.002, respectively) but was not significantly different between the SD and DD groups (P > 0.999) and between the ES and SO groups (P = 0.677). Body weight was significantly different among the four groups by the end of the study period (P < 0.001); body weight was significantly lower in the DD group than in the SD, ES, and SO groups (P = 0.010, P < 0.001, and P < 0.001, respectively) and in the SD group than in the SO group (P = 0.001), but it was not significantly different between the ES and SO groups (P = 0.344).
Conclusion
ISD reduced food intake and suppressed body weight gain in a rodent model.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- ISD:
-
Intragastric satiety-inducing device
- SD:
-
Single-disk
- DD:
-
Double-disk
- ES:
-
Esophageal stent
- SO:
-
Sham-operated
References
World Health Organization. Obesity and overweight: fact sheet. 2018 [updated 2018 February 16; cited 2019 July 28] Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259
Yanovski SZ, Yanovski JA (2014) Long-term drug treatment for obesity: a systematic and clinical review. JAMA 311:74–86
Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS Jr, Weidenbacher HJ, Livingston EH, Olsen MK (2016) Bariatric surgery and long-term durability of weight loss. JAMA Surg 151:1046–1055
Lee PC, Dixon J (2017) Medical devices for the treatment of obesity. Nat Rev Gastroenterol Hepatol 14:553
Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S (2015) Endoscopic bariatric therapies. Gastrointest Endosc 81:1073–1086
Myall P. New endoscopic stent can lead to 100% EWL. [updated 2012 June 5; cited 2019 July 28] Available from: https://www.bariatricnews.net/?q=node/102.
Dayyeh BKA, Edmundowicz S, Thompson CC (2017) Clinical practice update: expert review on endoscopic bariatric therapies. Gastroenterology 152:716–729
Camilleri M (2015) Peripheral mechanisms in appetite regulation. Gastroenterology 148:1219–1233
Tanaka-Shintani M, Watanabe M (2005) Distribution of ghrelin-immunoreactive cells in human gastric mucosa: comparison with that of parietal cells. J Gastroenterol 40:345–349
Vitari F, Di Giancamillo A, Deponti D, Carollo V, Domeneghini C (2012) Distribution of ghrelin-producing cells in the gastrointestinal tract of pigs at different ages. Vet Res Commun 36:71–80
Goitein D, Lederfein D, Tzioni R, Berkenstadt H, Venturero M, Rubin M (2012) Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients–a possible guide for efficient sleeve gastrectomy construction. Obes Surg 22:617–622
Park JH, Bakheet N, Na HK, Jeon JY, Yoon SH, Kim KY, Zhe W, Kim DH, Jung HY, Song HY (2019) A novel full sense device to treat obesity in a porcine model: preliminary results. Obes Surg 29:1521–1527
Yang J, Siddiqui AA, Kowalski TE, Loren DE, Khalid A, Soomro A, Mazhar SM, Rose J, Isby L, Kahaleh M, Kalra A, Sarkisian AM, Kumta NA, Nieto J, Sharaiha RZ (2017) Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surg Endosc 31:1414–1419
Musani AI, Jensen K, Mitchell JD, Weyant M, Garces K, Hsia D (2012) Novel use of a percutaneous endoscopic gastrostomy tube fastener for securing silicone tracheal stents in patients with benign proximal airway obstruction. J Bronchol Interv Pulmonol 19:121–125
Bradley D, Magkos F, Klein S (2012) Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 143:897–912
Acosta A, Abu Dayyeh BK, Port JD, Camilleri M (2014) Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut 63:687–695
Orellana ER, Covasa M, Hajnal A (2019) Neuro-hormonal mechanisms underlying changes in reward related behaviors following weight loss surgery: potential pharmacological targets. Biochem Pharmacol 164:106–114
Cummings DE, Shannon MH (2003) Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 138(4):389–396
Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128:175–191
Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88:2999–3002
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J (2011) Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 365:1597–1604
Gribble FM, Reimann F (2019) Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol 15:226–237
Funding
This study was supported by a grant from the National Key R&D Program of China (grant No. 2017YFC0107800 to X.L.) and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea (grant No. HI18C0631 to H.Y.J.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Yingen Luo, Xiaowu Zhang, Jiaywei Tsauo, Hwoon-Yong Jung, Ho-Young Song, He Zhao, Jingui Li, Tao Gong, Peng Song, and Xiao Li have no conflicts of interest or financial ties to disclose.
Ethical approval
All applicable institutional and/or national guidelines for the care and use of animals were followed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Luo, Y., Zhang, X., Tsauo, J. et al. Intragastric satiety-inducing device reduces food intake and suppresses body weight gain in a rodent model. Surg Endosc 35, 1052–1057 (2021). https://doi.org/10.1007/s00464-020-07467-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07467-x